LFG
AXSM icon

Larson Financial Group’s Axsome Therapeutics AXSM Stock Holding History

Larson Financial Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
72
+7
+11% +$1.52K ﹤0.01% 2076
2026
Q1 		$11K Sell
65
-4
-6% -$691 ﹤0.01% 2192
2025
Q4 		$12.6K Buy
69
+25
+57% +$3.49K ﹤0.01% 1982
2025
Q3 		$5.34K Buy
44
+43
+4,300% +$4.84K ﹤0.01% 2333
2025
Q2 		$104 Hold
1
– – ﹤0.01% 3158
2025
Q1 		$117 Buy
+1
New +$114 ﹤0.01% 2885

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Larson Financial Group's AXSM Position: Q2 2026 in Review

Larson Financial Group increased its Axsome Therapeutics (AXSM) stake by 11% in Q2 2026, buying an estimated $1.52K and bringing the position to 72 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Larson Financial Group first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Larson Financial Group held 72 shares of Axsome Therapeutics worth $17.6K as of Q2 2026.
  • Larson Financial Group bought 7 Axsome Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Axsome Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2076 holding.
  • Larson Financial Group first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.